What are the appropriate dosages of celecoxib (Celebrex) and Papase in patients with renal impairment?

Celecoxib Dosing in Renal Failure

Celecoxib does not require dose adjustment in mild to moderate renal impairment (GFR 35-60 mL/min), but should be avoided in severe renal insufficiency (GFR <30 mL/min), similar to other NSAIDs. 1, 2

Specific Dosing Recommendations

Mild to Moderate Renal Impairment (GFR 35-60 mL/min)

• No dose adjustment required 2
• FDA pharmacokinetic data shows celecoxib AUC is approximately 40% lower (not higher) in patients with chronic renal insufficiency compared to normal renal function 2
• Standard dosing can be used: 100-200 mg twice daily for osteoarthritis/rheumatoid arthritis 2

Severe Renal Insufficiency (GFR <30 mL/min)

• Celecoxib is NOT recommended 1, 2
• KDIGO guidelines explicitly state NSAIDs should be avoided in patients with GFR <30 mL/min 1
• This recommendation applies to all NSAIDs, including COX-2 selective inhibitors like celecoxib

Key Pharmacokinetic Considerations

The counterintuitive finding that celecoxib exposure decreases in renal impairment (rather than increases) is due to:

• Celecoxib is primarily eliminated via hepatic metabolism (CYP2C9), not renal excretion 2, 3
• Less than 3% of unchanged drug is recovered in urine 2
• The apparent plasma clearance increases by 47% in renal insufficiency 3

Important Caveats

Body weight matters more than renal function for celecoxib dosing:

• Patients <50 kg should start at the lowest recommended dose regardless of renal function 2
• Elderly patients have 40-50% higher drug exposure primarily due to lower body weight, not renal impairment 2

Renal safety profile:

• Celecoxib appears to spare renal hemodynamic function better than non-selective NSAIDs in elderly patients 4
• However, like all NSAIDs, celecoxib can still cause fluid retention, hypertension, and acute kidney injury 1, 5
• Recent evidence suggests celecoxib may be associated with fewer renal adverse events than non-selective NSAIDs 6

Regarding "Papase"

No evidence was found for a medication called "Papase" in renal failure dosing. This may refer to:

• A papain-containing enzyme preparation (not typically dose-adjusted for renal function)
• A regional/brand name not recognized in standard references
• A transcription error

If this refers to a proteolytic enzyme supplement, these generally do not require renal dose adjustment as they are not systemically absorbed.

Clinical Algorithm

1. Calculate GFR (using CKD-EPI or Cockcroft-Gault)
2. GFR ≥30 mL/min: Use standard celecoxib dosing (100-200 mg BID)
3. GFR <30 mL/min: Avoid celecoxib; consider alternative analgesics
4. If patient <50 kg: Start at 100 mg daily regardless of GFR
5. Monitor: Check GFR and potassium within 1 week if using with RAAS inhibitors 1